We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

C3BS Raises €19 Million Through a Private Placement

News   Jul 09, 2013

 
C3BS Raises €19 Million Through a Private Placement
 
 
 

RELATED ARTICLES

FDA Approves First Treatment for Postpartum Depression

News

The U.S. Food and Drug Administration today approved Zulresso (brexanolone) injection for intravenous (IV) use for the treatment of postpartum depression (PPD) in adult women. This is the first drug approved by the FDA specifically for PPD.

READ MORE

Fast-acting Psychedelic Eases Depression and Anxiety

News

Researchers have discovered that use of the synthetic psychedelic, 5-methocy-N,-N-dimethyltryptamine, appears to be associated with unintended improvements in self-reported depression and anxiety when given in a ceremonial group setting.

READ MORE

"Inflamm-aging" Results in Loss of Bone-healing Ability in the Elderly

News

The current study explains how this age-driven increase in immune signals diminishes the ability of stem cells, essential ingredients in bone repair, to multiply.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE